Curr Sex Health Rep (2017) 9:241–250 https://doi.org/10.1007/s11930-017-0128-z PRECLINICAL AND PSYCHOPHYSIOLOGY (F GUARRACI AND L MARSON, SECTION EDITORS) Preclinical Models for Assessment of Antidepressant Abuse Potential 1 2 M. F. Lazenka & B. A. Hutsell Published online: 17 October 2017 Springer Science+Business Media, LLC 2017 Abstract Introduction Purpose of Review This review considers the contribution of monoamine neurotransmitters to anhedonia, substance abuse, Depression has a worldwide prevalence of approximately 2– and sexual dysfunction and the relationship between antide- 5%. However, only half of patients in treatment remain symp- pressant efficacy and abuse liability. tom free and at least 10–20% of patients meet the criteria for Recent Findings The use of drugs with known abuse potential treatment-resistant depression . Furthermore, sexual dys- to treat depression, the addition of psychostimulants with an- function (including desire, arousal, orgasm, and ejaculation) tidepressants, and the development of novel antidepressants is a common comorbidity with depression [2, 3]and, unfortu- with preclinical evidence for abuse liability have increased in nately, current antidepressants can exacerbate sexual dysfunc- recent years. This is in contrast to the general lack of abuse tion . Therefore, new medications are clearly necessary. potential reported for traditional antidepressants such as selec- Development of pharmacotherapies
Current Sexual Health Reports – Springer Journals
Published: Oct 17, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera